The team will focus on identifying and analyzing bioactive compounds within certain plants. These compounds may possess properties that can mitigate cellular damage, reduce inflammation, and improve overall cellular function, all of which are key factors in the aging process. While the specific plant extracts under investigation have not yet been publicly disclosed, the researchers are employing advanced techniques to isolate and test their efficacy at a molecular level.

This exploration of natural compounds aligns with a growing interest in harnessing the power of nature to promote health and well-being. The potential benefits of identifying effective plant-based interventions for aging are significant, offering a potentially less invasive and more holistic approach to maintaining vitality.

For Generation X, who are increasingly mindful of maintaining their health and energy levels, this research direction is particularly relevant. As we navigate the midlife years, the prospect of naturally derived solutions to support healthy aging is appealing. It moves beyond the often-hyped “miracle cures” and delves into rigorous scientific investigation of what nature might offer.

The grant awarded to the Arkansas State University team underscores the increasing scientific recognition of the role that natural compounds could play in promoting longevity and healthspan. As their research progresses, the findings could offer valuable insights into how we can leverage the power of plant extracts to support healthier aging for ourselves and future generations.

The post New Research Explores Plant Extracts to Combat Aging appeared first on Raging in Place.

The tariffs, which include a 10% minimum tariff and broader reciprocal tariffs, are projected to raise the price of medical supplies, pharmaceuticals, and medical devices. An analysis cited by Fierce Healthcare suggests tariffs on Canadian-made drugs alone could add $750 million in costs. Hospitals and clinics may face increased expenses for essential equipment, potentially impacting budgets and patient care quality.  

Experts predict that hospitals could see operating income levels drop without cost savings or other revenue sources, according to Healthcare Dive.  

The tariffs also threaten to disrupt the availability of medical supplies and equipment, potentially leading to shortages or delays. Manufacturers may seek suppliers outside of Canada and Mexico, potentially leading to supply shortages. The complex global nature of pharmaceutical supply chains means tariffs could cause significant disruptions.  

Specific sectors expected to be affected include pharmaceuticals, where prescription drug prices could increase and potential shortages of essential medications could occur; medical devices, where tariffs could lead to increased costs and potential shortages; and personal protective equipment, where costs for items like gloves and masks could increase.  

Economists predict the tariffs could lead to increased inflation and slowed economic growth, potentially reducing funding for public health programs.  

Healthcare organizations and industry groups are lobbying for exemptions, particularly for medical devices and pharmaceuticals. Some are considering diversifying suppliers and proactively negotiating with existing ones to mitigate the impact.

The post Trump Tariffs Expected to Drive Up Healthcare Costs, Disrupt Supply Chains appeared first on Raging in Place.